Literature DB >> 27912199

Right ventricular dyssynchrony predicts clinical outcomes in patients with pulmonary hypertension.

Mitsushige Murata1, Toshimitsu Tsugu2, Takashi Kawakami2, Masaharu Kataoka2, Yugo Minakata2, Jin Endo2, Hikaru Tsuruta2, Yuji Itabashi2, Yuichiro Maekawa2, Keiichi Fukuda2.   

Abstract

BACKGROUND: RV dyssynchrony has been described in patients with pulmonary hypertension (PH) and is an independent predictor of clinical worsening; however, the optimal method for measuring RV dyssynchrony has not been fully established. This study aimed to investigate whether RV dyssynchrony is correlated with hemodynamics and prognosis in PH patients and to identify the best parameter for evaluating RV dyssynchrony.
METHODS: This study assessed 100 PH patients, measuring mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), and cardiac index (CI) by right heart catheterization (RHC). RV strain curves were obtained using two-dimensional speckle-tracking echocardiography (2DSTE), and time from QRS onset to maximum peak longitudinal strain (Tmax) or time to first peak (Tfirst) was measured. Difference in time between the earliest and the latest segment (TD) and standard deviation (SD) of T in 6 segments with RV apex (-SD6) and 4 segments without RV apex (-SD4) were also assessed.
RESULTS: Among all RV dyssynchrony parameters, Tmax-SD6 showed the strongest correlation with RV hemodynamics such as mPAP (R2=0.27, P<0.0001) and PVR (R2=0.22, P<0.0001). Univariate and multivariate Cox proportional hazard analyses showed that Tmax-SD6 significantly correlated with and independently predicted event-free survival in patients with PH.
CONCLUSIONS: RV dyssynchrony is a useful index for RV function and an independent predictor of clinical outcomes in patients with PH. In addition, the inclusion of apical motion is essential for the optimal assessment of RV dyssynchrony.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Dyssynchrony; Pulmonary hypertension; Right ventricle; Strain

Mesh:

Year:  2016        PMID: 27912199     DOI: 10.1016/j.ijcard.2016.11.244

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension.

Authors:  Mitsushige Murata; Takashi Kawakami; Masaharu Kataoka; Takashi Kohno; Yuji Itabashi; Keiichi Fukuda
Journal:  Pulm Circ       Date:  2017-12-18       Impact factor: 3.017

2.  Preliminary Study of Right Ventricular Dyssynchrony Under High-Altitude Exposure: Determinants and Impacts.

Authors:  Yuanqi Yang; Chuan Liu; Jingdu Tian; Xiaohan Ding; Shiyong Yu; Shizhu Bian; Jie Yang; Zhexue Qin; Jihang Zhang; Jingbin Ke; Fangzhengyuan Yuan; Chen Zhang; Rongsheng Rao; Lan Huang
Journal:  Front Physiol       Date:  2020-07-02       Impact factor: 4.566

3.  Usefulness of scoring right ventricular function for assessment of prognostic factors in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Yoshihiro Kamimura; Naoki Okumura; Shiro Adachi; Shigetake Shimokata; Fumitaka Tajima; Yoshihisa Nakano; Akihiro Hirashiki; Toyoaki Murohara; Takahisa Kondo
Journal:  Heart Vessels       Date:  2018-04-27       Impact factor: 2.037

4.  Impact of right ventricular dyssynchrony on prognosis of patients with idiopathic pulmonary arterial hypertension.

Authors:  Xiao-Ling Cheng; Bing-Yang Liu; Wei-Chun Wu; Wen Li; Li Huang; Tao Yang; Zhi-Hong Liu; Hao Wang; Jian-Guo He; Chang-Ming Xiong
Journal:  Pulm Circ       Date:  2019-10-23       Impact factor: 3.017

5.  Upgrade of cardiac resynchronization therapy by utilizing additional His-bundle pacing in patients with inotrope-dependent end-stage heart failure: a case series.

Authors:  Masako Baba; Kentaro Yoshida; Yuichi Hanaki; Masayoshi Yamamoto; Yasutoshi Shinoda; Noriyuki Takeyasu; Akihiko Nogami
Journal:  Eur Heart J Case Rep       Date:  2020-11-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.